Clover Biopharmaceuticals Welcomes Nicholas Jackson, Ph.D., as Global R&D President Clover Biopharmaceuticals announces Nicholas Jackson, Ph.D., as President of Global R&D and Alliances to spearhead vaccine development and collaborations.

Clover Biopharmaceuticals Welcomes Nicholas Jackson, Ph.D., as Global R&D President #China #Shanghai #Vaccine_Development #Clover_Biopharma #Nicholas_Jackson